Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
11/21/2024 05:00 PM EST Business Wire Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
11/20/2024 08:00 AM EST Business Wire Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
11/14/2024 04:01 PM EST Business Wire Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/07/2024 08:00 AM EST Business Wire Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
10/14/2024 08:00 AM EDT Business Wire Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
09/25/2024 08:00 AM EDT Business Wire OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
09/18/2024 08:00 AM EDT Business Wire Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance(TM), at the 59th Annual Inner Ear Biology Workshop
08/13/2024 08:00 AM EDT Business Wire Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
08/08/2024 04:05 PM EDT Business Wire Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
08/01/2024 08:00 AM EDT Business Wire Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
Page